| Year |
Citation |
Score |
| 2020 |
Nollet EA, Cardo-Vila M, Ganguly SS, Tran JD, Schulz VV, Cress A, Corey E, Miranti CK. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene. PMID 32565538 DOI: 10.1038/S41388-020-1370-9 |
0.416 |
|
| 2019 |
Ganguly SS, Hostetter G, Tang L, Frank SB, Saboda K, Mehra R, Wang L, Li X, Keller ET, Miranti CK. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3. Oncogene. PMID 31467432 DOI: 10.1038/S41388-019-0977-1 |
0.438 |
|
| 2018 |
Ganguly SS, Daft PG, Cao J, Meng X, Zhong ZA, Vander Ark A, Meadows A, Madaj Z, Williams B, Li X. Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions. Cancers. 10. PMID 30469488 DOI: 10.3390/Cancers10120463 |
0.37 |
|
| 2018 |
Nollet E, Ganguly S, Schulz V, Corey E, Miranti CK. Abstract A083: Cell adhesion to laminin, by integrin α6β1, mediates drug resistance to PI3K in castration-resistant prostate cancer through AR-dependent induction of BNIP3 Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A083 |
0.501 |
|
| 2018 |
Ark AV, Woodford E, Meng X, Ganguly S, Zhang X, Madaj Z, Li X. Abstract 4898: Reduction of TGFBR2 in osteoblasts by enzalutamide causes drug resistance in prostate cancer bone metastasis Cancer Research. 78: 4898-4898. DOI: 10.1158/1538-7445.Am2018-4898 |
0.393 |
|
| 2014 |
Ganguly SS, Li X, Miranti CK. The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis. Frontiers in Oncology. 4: 364. PMID 25566502 DOI: 10.3389/Fonc.2014.00364 |
0.386 |
|
| 2014 |
Fiore LS, Ganguly SS, Sledziona J, Cibull ML, Wang C, Richards DL, Neltner JM, Beach C, McCorkle JR, Kaetzel DM, Plattner R. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene. 33: 4508-20. PMID 24096484 DOI: 10.1038/Onc.2013.399 |
0.623 |
|
| 2013 |
Sims JT, Ganguly SS, Bennett H, Friend JW, Tepe J, Plattner R. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. Plos One. 8: e55509. PMID 23383209 DOI: 10.1371/Journal.Pone.0055509 |
0.63 |
|
| 2013 |
Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker M, Cibull ML, Chi W, Plattner R. Abstract C51: c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion, proliferation, survival, and drive metastatic progression Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C51 |
0.676 |
|
| 2012 |
Ganguly SS, Plattner R. Activation of abl family kinases in solid tumors. Genes & Cancer. 3: 414-25. PMID 23226579 DOI: 10.1177/1947601912458586 |
0.635 |
|
| 2012 |
Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker MA, Cibull ML, Wang C, Novak M, Kaetzel DM, Plattner R. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene. 31: 1804-16. PMID 21892207 DOI: 10.1038/Onc.2011.361 |
0.665 |
|
| 2009 |
Sims JT, Ganguly S, Fiore LS, Holler CJ, Park ES, Plattner R. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner. Biochemical Pharmacology. 78: 249-60. PMID 19427998 DOI: 10.1016/J.Bcp.2009.04.007 |
0.573 |
|
| Show low-probability matches. |